Pituitary Adenylate Cyclase-Activating Polypeptide (PACAP) and Sudden Infant Death Syndrome: A Potential Model for Investigation
International Journal of Molecular Sciences · 2023
DOI: 10.3390/ijms242015063 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Dénes Tóth und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Forensic Medicine, University of Pécs Medical School, Szigeti út 12, H-7624 Pécs, Hungary. Hauptthemen laut MEDLINE: Pituitary Adenylate Cyclase-Activating Polypeptide, Receptors, Pituitary Adenylate Cyclase-Activating Polypeptide, Type I, Sudden Infant Death. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 87 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry for Innovation and Technology, Hungarian Scientific Research Fund, Hungarian Academy of Sciences.
Abstract (Originalsprache)
Sudden infant death syndrome (SIDS) represents a significant cause of post-neonatal mortality, yet its underlying mechanisms remain unclear. The triple-risk model of SIDS proposes that intrinsic vulnerability, exogenous triggers, and a critical developmental period are required for SIDS to occur. Although case–control studies have identified potential risk factors, no in vivo model fully reflects the complexities observed in human studies. Pituitary adenylate cyclase-activating polypeptide (PACAP), a highly conserved neuropeptide with diverse physiological functions, including metabolic and thermal regulation, cardiovascular adaptation, breathing control, stress responses, sleep–wake regulation and immunohomeostasis, has been subject to early animal studies, which revealed that the absence of PACAP or its specific receptor (PAC1 receptor: PAC1R) correlates with increased neonatal mortality similar to the susceptible period for SIDS in humans. Recent human investigations have further implicated PACAP and PAC1R genes as plausible contributors to the pathomechanism of SIDS. This mini-review comprehensively synthesizes all PACAP-related research from the perspective of SIDS and proposes that PACAP deficiency might offer a promising avenue for studying SIDS.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Forensic Medicine, University of Pécs Medical School, Szigeti út 12, H-7624 Pécs, Hungary.
- Department of Anatomy, HUN-REG-PTE PACAP Research Team, Centre for Neuroscience, University of Pécs Medical School, Szigeti út 12, H-7624 Pécs, Hungary.
ORCID-Profile: Dénes Tóth, Gábor Simon
Förderung
- Ministry for Innovation and Technology
- Hungarian Scientific Research Fund
- Hungarian Academy of Sciences
- ELKH
- Thematic Excellence Program 2021 Health Sub-program of the Ministry for Innovation and Technology in Hungary
- NAP 3.0
- ELKH-PTE
Zitieren
APA
Tóth, D., Simon, G., & Reglődi, D. (2023). Pituitary Adenylate Cyclase-Activating Polypeptide (PACAP) and Sudden Infant Death Syndrome: A Potential Model for Investigation. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms242015063
Vancouver
Tóth D, Simon G, Reglődi D. Pituitary Adenylate Cyclase-Activating Polypeptide (PACAP) and Sudden Infant Death Syndrome: A Potential Model for Investigation. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms242015063
BibTeX
@article{Tth2023,
author = {Tóth, Dénes and Simon, Gábor and Reglődi, Dóra},
title = {Pituitary Adenylate Cyclase-Activating Polypeptide (PACAP) and Sudden Infant Death Syndrome: A Potential Model for Investigation},
journal = {International Journal of Molecular Sciences},
year = {2023},
doi = {10.3390/ijms242015063}
}
EUVIMED